共 50 条
- [44] High Rate of Adherence to Urate-Lowering Treatment in Patients with Gout: Who’s to Blame? [J]. Rheumatology and Therapy, 2020, 7 : 1011 - 1019
- [47] Rebranding Gout: Could a Name Change for Gout Improve Adherence to Urate-Lowering Therapy? [J]. Therapeutic Innovation & Regulatory Science, 2021, 55 : 138 - 141
- [48] Case 8: Initiation of urate-lowering therapy for standard advanced gout [J]. AMERICAN JOURNAL OF MEDICINE, 2006, 119 : 25 - 28
- [49] COMPARISON OF URATE-LOWERING EFFICACY AND SAFETY OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS [J]. HETEROCYCLIC LETTERS, 2016, 6 (01): : 133 - 147
- [50] Prophylaxis for acute gout flares after initiation of urate-lowering therapy [J]. RHEUMATOLOGY, 2014, 53 (11) : 1920 - 1926